E. Kintsurashvili et al., Effects of ANG II on bradykinin receptor gene expression in cardiomyocytesand vascular smooth muscle cells, AM J P-HEAR, 281(4), 2001, pp. H1778-H1783
Citations number
31
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Bradykinin has vasodilatory and tissue-protective effects exerted via its B
-2 type receptor, whereas the B-1 receptor is constitutively absent but ind
ucible by inflammation and toxins. In previous studies, we found that B-2 r
eceptor gene knockout mice exhibit overexpression of the B-1 receptor, whic
h assumes a vasodilatory function and is further upgraded in renovascular h
ypertension. The present study was designed to explore the effects of exces
s angiotensin II (ANG II) on B-1 receptor and B-2 receptor gene expression
in mouse cardiomyocytes and rat vascular smooth muscle cells (VSMC) in vivo
(after a 3-day infusion of 30 ng/min ANG II in 11 wild-type and in 13 gene
tically engineered mice with deleted B-2 receptor gene) and in vitro (ANG I
I added in rat VSMC culture in the presence or absence of AT(1) or AT(2) re
ceptor antagonist), Expression of B-1 and B-2 receptor mRNA was assessed by
reverse transcriptase-polymerase chain reaction. ANG II infusion caused up
regulation by 30% of the already significantly overexpressed B-1 receptors
in cardiomyocytes of the B-2 receptor gene knockout mice, but in the wild-t
ype mice it upregulated only the B-2 receptor mRNA by 47%. The addition of
ANG II in VSMC culture produced a time-dependent induction of B-1 and upreg
ulation of B-2 receptor gene expression, maximal at 3 h (by fivefold), decl
ining almost to baseline by 24 h. The addition of losartan completely, bloc
ked this effect, whereas the AT(2) blocker PD-123319 made no difference, in
dicating that this is an AT(1)-mediated effect of ANG II. The data indicate
that excess ANG II in subpressor doses in vivo upregulates expression of t
he B-2 receptor, but in its absence, the already overexpressed B-1 receptor
is further upregulated, evidently assuming a counterregulatory response; i
n vitro, it transiently upregulates both bradykinin receptors.